Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

3.670 -0.100 (-2.65%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
News headline image
Short Squeeze Frenzy Fuels October's Market Rebound: A Closer Look at Bearish Bets and Bullish Surges
The U.S. stock market has staged a remarkable recovery in October 2025, with major indices reclaiming lost ground amidst a confluence of positive corporate earnings and improving macroeconomic... 
Via MarketMinute
Topics Economy Stocks World Trade
News headline image
Up 25% in 1 Month, Is This Stock a Buy? ↗
It might look like this beaten-down AI-focused company is finally bouncing back, but don't be too quick to pull the trigger. 
Via The Motley Fool
Topics Animal Testing Artificial Intelligence
Recursion Pharmaceuticals (RXRX) CEO Sells 100,000 Shares ↗
Via The Motley Fool
News headline image
WW International, Replimune Group, Datavault AI, GRAIL And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
Topics Artificial Intelligence
News headline image
3 Growth Stocks to Invest $1,000 in Right Now ↗
Not every promising prospect is currently priced too richly relative to its risk. 
Via The Motley Fool
News headline image
Most active stocks in Thursday's session ↗
Stay updated with the latest market activity on Thursday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight. 
Via Chartmill
News headline image
Is Recursion Pharmaceuticals a Millionaire Maker? ↗
This is the only biotech stock to attract an investment from artificial intelligence (AI) giant Nvidia. 
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering
News headline image
Morgan Stanley, T1 Energy, Bunge Global, Bank of America And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
AI Agents Usher in a New Era of Pharmaceutical Discovery: Accelerating Cures to Market
The pharmaceutical industry stands on the precipice of a revolutionary transformation, driven by the burgeoning power of artificial intelligence (AI) agents. These sophisticated, autonomous systems are... 
Via TokenRing AI
Topics Artificial Intelligence Intellectual Property
News headline image
Absci's AI Revolution: A New Era for Drug Discovery or a Rocky Road Ahead?
Absci (NASDAQ: ABSI), a pioneer in AI-driven drug discovery, is making significant strides with its "Integrated Drug Creation™ Platform," promising to revolutionize how new medicines are brought to... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk ↗
Absci's AI drug development platform is compelling, and its pipeline is promising...but can the company overcome execution hurdles to live up to analyst hype? 
Via MarketBeat
Topics Artificial Intelligence
News headline image
4 Healthcare Stocks to Buy Now ↗
As investors crowd into AI names at record highs, these three healthcare stocks offer more compelling valuations. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Costco, AMD, Recursion Pharmaceuticals, Cipher Mining And Snowflake: Why These 5 Stocks Are On Investors' Radars Today ↗
On Wednesday, major U.S. indices closed mixed, with the Nasdaq rising 1.1% to 23,043.38 and the S&P 500 slipping nearly 0.6% to 6,753.72. The Dow Jones Industrial Average was unchanged at... 
Via Benzinga
Topics Stocks
News headline image
What's Going On With Recursion Pharmaceuticals Stock On Wednesday? ↗
Recursion Pharmaceuticals' stock rises on heavy trading volume, with investors eyeing its AI-designed cancer drug REC-3565 and extended cash runway. 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
Decoding Life's Blueprint: New Tech Maps RNA-Protein Interactions, Unlocking Disease Cures
A monumental leap in biomedical research has been announced with the development of a breakthrough technology capable of mapping the entire intricate network of RNA-protein interactions within human... 
Via MarketMinute
Topics Artificial Intelligence Derivatives
News headline image
AI Revolutionizes Professional Services: A New Era for Doctors, Lawyers, and Consultants
As of October 1, 2025, Artificial Intelligence (AI) has transcended its nascent stages, becoming an indispensable force in high-value professional tasks across medicine, law, and consulting. This... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
Nvidia Has Invested in These 6 Companies. Should You Follow Suit? ↗
The world's most valuable company holds stakes in a number of smaller tech players. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Where Will Recursion Pharmaceuticals Be in 5 Years? ↗
Could investing in this stock be an underrated way to profit from the rapidly expanding AI industry? 
Via The Motley Fool
Topics Animal Testing Artificial Intelligence
News headline image
The Biotech Stock That's Too Risky for Most Investors ↗
It's unclear how long it's going to be before this company has a product to sell. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
10 Hidden-Gem AI Stocks to Buy Right Now ↗
From AI-powered insurance bots to drug discovery platforms, these overlooked stocks offer pure-play exposure to artificial intelligence without trillion-dollar valuations. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Cramer's Friday Watchlist: AI Soars as Consumer Stumbles Amidst Economic Divide
As the trading week draws to a close on Friday, September 26, 2025, Jim Cramer, the influential host of CNBC's "Mad Money," has once again offered his discerning insights into the stock market's... 
Via MarketMinute
Topics Artificial Intelligence Economy Energy
News headline image
Jim Cramer Says This Financial Stock Is A 'Total Spec,' Likes Dutch Bros, ↗
On CNBC's “Mad Money Lightning Round,” Jim Cramer said he likes Dutch Bros (NYSE: BROS). He recommended buying some now and then buying some of the stock in the $40s. 
Via Benzinga
News headline image
Prediction: 2 Stocks That Will Be Worth More Than BigBear.ai 5 Years From Now ↗
BigBear.ai is bigger than both of these AI-focused companies now. That could change. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
The Pharmaceutical Revolution: AI, Gene Therapies, and Obesity Drugs Reshape a Trillion-Dollar Market
The global pharmaceutical sector stands at the precipice of a monumental transformation, driven by an unprecedented convergence of scientific breakthroughs, technological innovation, and evolving... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Lilly's AI Gambit: TuneLab Poised to Reshape Biotech Drug Discovery Landscape
Eli Lilly and Company (NYSE: LLY) has unveiled its groundbreaking TuneLab Platform, an artificial intelligence (AI) and machine learning (ML) initiative designed to democratize advanced drug discovery... 
Via MarketMinute
Topics Animal Testing Artificial Intelligence Intellectual Property
News headline image
Nvidia Has $4.3 Billion Invested in These 6 Artificial Intelligence (AI) Stocks. Here's the Best of the Bunch. ↗
Most of Nvidia's AI bets are riding on one stock. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
What Analysts Are Saying About Recursion Pharmaceuticals Stock ↗
 
Via Benzinga
News headline image
When You Buy Nvidia Stock, You Get a Bonus: An Artificial Intelligence (AI) ETF of Sorts ↗
Nvidia's six-stock portfolio of publicly traded AI stocks was worth $4.3 billion at the end of the second quarter, and the company also owns stakes in many privately held AI start-ups. 
Via The Motley Fool
Topics Artificial Intelligence ETFs Regulatory Compliance
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.